US Broker Ratings

Senseonics Holdings, Inc. (SENS) Stock Analysis: A 138.85% Potential Upside in the Healthcare Sector

Senseonics Holdings, Inc. (SENS) is making waves in the healthcare sector with its innovative approach to diabetes management. As a commercial-stage medical technology company, Senseonics focuses on the development and..

Aura Biosciences, Inc. (AURA) Stock Analysis: Assessing a Potential 300% Upside in Biotech Innovation

Aura Biosciences, Inc. (NASDAQ: AURA) stands out in the biotechnology sector, attracting significant attention from investors due to its innovative approach to treating solid tumors. A clinical-stage company, Aura is..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 303% Potential Upside in Gene Therapy Innovation

Abeona Therapeutics Inc. (NASDAQ: ABEO) stands out in the biotechnology sector with its promising advancements in gene and cell therapies, targeting life-threatening diseases. With a focus on precision medicine, the..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Unpacking the 74.59% Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) offers a fascinating opportunity for investors interested in the biotechnology sector, particularly those focused on innovative approaches to genetically defined diseases. With a market capitalization..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Potential 346% Upside with Innovative mRNA Therapies

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is capturing the attention of investors with its pioneering work in mRNA-based therapies and a staggering potential upside of 346.81%. The San Diego-based biotechnology..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 42.86% Potential Upside in the Cell Analysis Solutions Market

Cytek Biosciences, Inc. (NASDAQ: CTKB), a leader in the healthcare sector specializing in medical devices, has garnered notable attention from investors due to its innovative cell analysis solutions. The company,..

Rigel Pharmaceuticals (RIGL) Stock Analysis: Biotech Innovator with a 44% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a dynamic player in the biotechnology sector, is capturing investor attention with its innovative therapies and substantial growth potential. As a company focused on addressing..

agilon health, inc. (AGL) Investor Outlook: Exploring a 173% Potential Upside Despite Challenges

The healthcare sector is a dynamic arena, often characterized by rapid advancements and persistent challenges. agilon health, inc. (AGL), a company specializing in healthcare services for seniors, finds itself at..

The Pennant Group, Inc. (PNTG) Investor Outlook: Analyzing a 17.3% Potential Upside Amid Robust Revenue Growth

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector with its impressive growth trajectory and optimistic analyst outlook. As a participant in the Medical Care Facilities..

Wave Life Sciences Ltd. (WVE) Investor Outlook: Analyzing a 163% Potential Upside in Biotechnology

Wave Life Sciences Ltd. (NASDAQ: WVE) is capturing the attention of investors with its compelling potential upside of 163.21%, as outlined by analyst ratings. Operating within the innovative and fast-evolving..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Gem with an 87.5% Potential Upside

MiMedx Group, Inc. (MDXG), a key player in the biotechnology sector, has captured investor attention with its innovative approach to healthcare solutions. Specializing in the development and distribution of placental..

Evolent Health, Inc (EVH) Stock Analysis: Uncovering a Potential 204.66% Upside

Evolent Health, Inc. (NYSE: EVH) stands at a pivotal moment, capturing the attention of investors with the prospect of a remarkable 204.66% upside, according to analyst ratings. Positioned within the..

Mineralys Therapeutics, Inc. (MLYS): An 85.82% Potential Upside Sparks Investor Interest

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the healthcare sector, specifically within the biotechnology industry, as it continues its pursuit of innovative treatments for conditions driven by dysregulated..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, continues to capture the attention of investors eager to explore opportunities within the healthcare sector. Specializing in therapies for autoimmune diseases,..

Biohaven Ltd. (BHVN) Stock Analysis: A Biotech Challenger with an 84% Potential Upside

Biohaven Ltd. (NASDAQ: BHVN), a prominent player in the biotechnology sector, continues to pique investor interest with its robust pipeline and strategic partnerships. With a market capitalization of $1.51 billion,..

Janux Therapeutics, Inc. (JANX) Investor Outlook: A Potential 383.93% Upside in the Biotech Sector

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning name in the biotechnology industry, has captured investor attention with its cutting-edge immunotherapy platforms and a notably high potential upside of 383.93%. As..

Harrow, Inc. (HROW) Stock Analysis: A 48% Potential Upside in the Eye-Care Pharma Sector

Harrow, Inc. (NASDAQ: HROW), a prominent player in the healthcare sector, specializes in the development of ophthalmic pharmaceutical products. Headquartered in Nashville, Tennessee, this company has carved out a niche..

SS Innovations International (SSII) Stock Analysis: Exploring a Potential Growth Story in Surgical Robotics

SS Innovations International Inc. (SSII), a prominent player in the healthcare sector specializing in medical devices, is making waves in the surgical robotics industry. With a market capitalization of $837.68..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring 53.4% Revenue Growth and a 7.73% Upside Potential

Kestra Medical Technologies, Ltd. (KMTS), a notable player in the healthcare sector, is making waves in the medical instruments and supplies industry. Focused on enhancing cardiovascular patient outcomes through innovative..

LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Exploring an 18% Potential Upside in the Medical Devices Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical instruments and supplies industry. Based in Burlington, Massachusetts, LeMaitre Vascular..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds